Theriva Biologics Inc (TOVX)

[FUNMAN]

Too few care about the news. As commercialization happens and revenues start coming in, more people will start following AEN. They will regret not having found it sooner.

As for anyone's concern about more dilution, don't fret. Those past private placements were far above the present stock price and well worth the cash infusion to all of us. The O/S is still a meager 28 million. Smart money will be drawn to this company's management.

AEN is obviously committed to increasing shareholder value. They're capitalizing the company correctly, and steadily moving towards profitability with products that will have a recurring revenue stream.